SU648080A3 - Способ получени 1-трет.-бутиламино3-(2,5-дихлорфенокси)-2пропанола, его соли, рацемата или оптического антипода - Google Patents

Способ получени 1-трет.-бутиламино3-(2,5-дихлорфенокси)-2пропанола, его соли, рацемата или оптического антипода

Info

Publication number
SU648080A3
SU648080A3 SU772457128A SU2457128A SU648080A3 SU 648080 A3 SU648080 A3 SU 648080A3 SU 772457128 A SU772457128 A SU 772457128A SU 2457128 A SU2457128 A SU 2457128A SU 648080 A3 SU648080 A3 SU 648080A3
Authority
SU
USSR - Soviet Union
Prior art keywords
propanol
salt
tert
racemate
butylamino
Prior art date
Application number
SU772457128A
Other languages
English (en)
Russian (ru)
Inventor
Хайош Андор
Фекете Мартон
Кюрти Марианна
Ланг Тибор
Толдь Лайош
Борвендег Янош
Надь Ласло
Элек Шандор
Полгари Иштван
Элекеш Иштван
Original Assignee
Рихтер Гедеон Ведьесети Дьяр Рт (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Ведьесети Дьяр Рт (Фирма) filed Critical Рихтер Гедеон Ведьесети Дьяр Рт (Фирма)
Application granted granted Critical
Publication of SU648080A3 publication Critical patent/SU648080A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SU772457128A 1976-03-02 1977-03-01 Способ получени 1-трет.-бутиламино3-(2,5-дихлорфенокси)-2пропанола, его соли, рацемата или оптического антипода SU648080A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76GO00001331A HU172137B (hu) 1976-03-02 1976-03-02 Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Publications (1)

Publication Number Publication Date
SU648080A3 true SU648080A3 (ru) 1979-02-15

Family

ID=10996805

Family Applications (1)

Application Number Title Priority Date Filing Date
SU772457128A SU648080A3 (ru) 1976-03-02 1977-03-01 Способ получени 1-трет.-бутиламино3-(2,5-дихлорфенокси)-2пропанола, его соли, рацемата или оптического антипода

Country Status (25)

Country Link
US (1) US4310549A (enExample)
JP (1) JPS5923299B2 (enExample)
AT (1) AT348507B (enExample)
AU (1) AU508766B2 (enExample)
BE (1) BE851938A (enExample)
CA (1) CA1091254A (enExample)
CH (1) CH627732A5 (enExample)
CS (1) CS190340B2 (enExample)
DD (1) DD128610A5 (enExample)
DE (1) DE2709109C3 (enExample)
DK (1) DK143554C (enExample)
FI (1) FI65231C (enExample)
FR (1) FR2342956A1 (enExample)
GB (1) GB1573191A (enExample)
HU (1) HU172137B (enExample)
IL (1) IL51574A (enExample)
IN (1) IN144243B (enExample)
KE (1) KE3340A (enExample)
MY (1) MY8500104A (enExample)
NL (1) NL7702170A (enExample)
NO (1) NO141989C (enExample)
PL (1) PL103734B1 (enExample)
SE (1) SE440647B (enExample)
SU (1) SU648080A3 (enExample)
YU (1) YU40813B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20050890A (sr) * 2003-05-30 2007-12-31 Ranbaxy Laboratories Limited, Supstituisani pirol derivati
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
TW200811101A (en) * 2006-07-14 2008-03-01 Ranbaxy Lab Ltd Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569692A5 (enExample) 1971-03-17 1975-11-28 Richter Gedeon Vegyeszet
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives

Also Published As

Publication number Publication date
CA1091254A (en) 1980-12-09
NO141989C (no) 1980-06-11
IN144243B (enExample) 1978-04-15
BE851938A (fr) 1977-09-01
JPS5923299B2 (ja) 1984-06-01
MY8500104A (en) 1985-12-31
KE3340A (en) 1983-11-25
NO141989B (no) 1980-03-03
AU2279577A (en) 1978-09-07
FI65231B (fi) 1983-12-30
SE7702251L (sv) 1977-09-03
GB1573191A (en) 1980-08-20
DK143554B (da) 1981-09-07
DK143554C (da) 1982-03-08
DD128610A5 (de) 1977-11-30
AU508766B2 (en) 1980-04-03
DE2709109A1 (de) 1977-09-15
PL103734B1 (pl) 1979-07-31
FI65231C (fi) 1984-04-10
US4310549A (en) 1982-01-12
FR2342956B1 (enExample) 1982-11-26
DE2709109C3 (de) 1980-09-18
DK88577A (da) 1977-09-03
FR2342956A1 (fr) 1977-09-30
FI770651A7 (enExample) 1977-09-03
ATA134177A (de) 1978-07-15
YU40813B (en) 1986-06-30
IL51574A0 (en) 1977-05-31
NL7702170A (nl) 1977-09-06
CH627732A5 (de) 1982-01-29
AT348507B (de) 1979-02-26
IL51574A (en) 1980-01-31
NO770688L (no) 1977-09-05
CS190340B2 (en) 1979-05-31
SE440647B (sv) 1985-08-12
DE2709109B2 (de) 1980-01-17
HU172137B (hu) 1978-06-28
JPS52122328A (en) 1977-10-14
YU54977A (en) 1982-10-31

Similar Documents

Publication Publication Date Title
SU1277895A3 (ru) Способ получени цис,эндо-2-азабицикло-(3,3,0)-октан-3-карбоновой кислоты или ее эфиров или кислотно-аддитивных солей
SU577982A3 (ru) Способ получени 2-тетрагидрофурфурил6,7-бензоморфанов или их солей
DK157026B (da) Fremgangsmaade til fremstilling af 7-oed-alfa-amino-alfa-(p-hydroxy-phenyl)acetamidoaa-3-methyl-cephem-4-carboxylsyre
US4319040A (en) Process for the production of optically active threo-3-(3,4-dihydroxyphenyl)serine
SU648080A3 (ru) Способ получени 1-трет.-бутиламино3-(2,5-дихлорфенокси)-2пропанола, его соли, рацемата или оптического антипода
KR960008664B1 (ko) 2,6-디클로로디페닐아미노아세트산 유도체류의 제조공정
US4417070A (en) Process for preparing an optical active ester of naphthylpropionic acid
US4305887A (en) Process for obtaining the enantiomeric forms of 4-cyano-1-[N-methyl-N-(2'-{3",4"-dimethoxyphenyl}-ethyl)-amino]-5-methyl-4-(3',4',5'-trimethoxyphenyl)-hexane and of salts thereof
SU1282815A3 (ru) Способ получени оптически активных транс-1Н-пропил-6-оксо-гидрохинолинов
SU1491339A3 (ru) Способ получени кристаллической формы моноэтаноламиновой соли N-(2-пиридил)-2-метил-4-окси-2Н-1,2-бензотиазин-3-карбоксамида 1,1-диоксида-полиморфа @
JP2780800B2 (ja) セフタジジムジ塩酸塩ギ酸溶媒和物
SU554816A3 (ru) Способ получени азотсодержащих полициклических соединений или их солей, или рацематов, или оптических антиподов
NO167460B (no) Fremgangsmaate til rensing av et antibiotikumholdig materiale.
CS195746B2 (en) Process for preparing crystalline methanolate of natrium salt of cephamandole
JPS6351135B2 (enExample)
JP2518014B2 (ja) α−置換酢酸の精製方法
SU1731046A3 (ru) Способ получени правовращающих производных оксиизоиндолинила или их фармацевтически приемлемых солей
US5087698A (en) Process for the optical resolution of dropopizine
US4118501A (en) Thiazolidine derivatives
JPS63145256A (ja) 光学活性ホモフエニルアラニンの製造法及び中間体
HU198073B (en) Process for producing (+)-3-(3-pyridyl)-1h, 3h-pyrrolo (1,2-c/thiazole-7-carboxylic acid
JPS638954B2 (enExample)
US3931409A (en) Composition and method for treatment of hyperuricemia
SU501670A3 (ru) Способ получени производных циклопентено-хинолона
US5952494A (en) Method for the preparation of pyrido benzoxazine derivatives